169447-74-9Relevant articles and documents
17 Beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
-
Page 16, (2008/06/13)
In its many embodiments, the present invention provides a novel class of compounds as inhibitors of type 3 17β-hydroxysteroid dehydrogenase, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of
2-Substituted piperazines as constrained amino acids. Application to the synthesis of potent, non carboxylic acid inhibitors of farnesyltransferase [1]
Williams,Ciccarone,MacTough,Bock,Conner,Davide,Hamilton,Koblan,Kohl,Kral,Mosser,Omer,Pompliano,Rands,Schaber,Shah,Wilson,Gibbs,Graham,et al.
, p. 1345 - 1348 (2007/10/03)
-